Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5.17M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+9.9M
-
Total reported value, excl. options
-
$956K
-
Value change
-
+$583K
-
Number of buys
-
15
-
Number of sells
-
-7
-
Price
-
$0.06
Significant Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q4 2024
26 filings reported holding CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
.
Largest 10 shareholders include ARCH Venture Management, LLC (9.39M shares), Avantax Planning Partners, Inc. (2.59M shares), Cubist Systematic Strategies, LLC (333K shares), Vanguard Personalized Indexing Management, LLC (235K shares), GOLDMAN SACHS GROUP INC (162K shares), CANTOR FITZGERALD, L. P. (155K shares), Selkirk Management LLC (121K shares), Tower Research Capital LLC (TRC) (73.7K shares), MILLENNIUM MANAGEMENT LLC (63.1K shares), and JANE STREET GROUP, LLC (57.5K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.